Literature DB >> 2532753

Cerebral glucose consumption measured by PET in patients with and without psychiatric symptoms of Huntington's disease.

T Kuwert1, H W Lange, K J Langen, H Herzog, A Aulich, L E Feinendegen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2532753     DOI： 10.1016/0165-1781(89)90090-5

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN： 0165-1781            Impact factor:   3.222


× No keyword cloud information.
  5 in total

1.  Psychiatric disorders in preclinical Huntington's disease.

Authors:  Camille L Julien; Jennifer C Thompson; Sue Wild; Pamela Yardumian; Julie S Snowden; Gwen Turner; David Craufurd
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-18       Impact factor: 10.154

2.  Behavioral Changes in Huntington Disease

Authors:  Jason Brandt
Journal:  Cogn Behav Neurol       Date:  2018-03       Impact factor: 1.600

Review 3.  An overview of psychiatric symptoms in Huntington's disease.

Authors:  K E Anderson; K S Marder
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

4.  Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease.

Authors:  Luana Naia; Teresa Cunha-Oliveira; Joana Rodrigues; Tatiana R Rosenstock; Ana Oliveira; Márcio Ribeiro; Catarina Carmo; Sofia I Oliveira-Sousa; Ana I Duarte; Michael R Hayden; A Cristina Rego
Journal:  J Neurosci       Date:  2017-01-25       Impact factor: 6.167

Review 5.  Role of cerebral cortex in the neuropathology of Huntington's disease.

Authors:  Ana M Estrada-Sánchez; George V Rebec
Journal:  Front Neural Circuits       Date:  2013-02-18       Impact factor: 3.492
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.